Diagnostic Center | June 16, 2022
Lupin Diagnostics launches its first regional reference lab in Patna
Expanding diagnostics footprint in East India
Expanding diagnostics footprint in East India
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
A primary investment of Rs 194.4 crore has been made
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Cipla has reported consolidated financial results for the period ended March 31, 2022
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
It is expanding the diagnostics business footprint in North East India
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Subscribe To Our Newsletter & Stay Updated
